DADA’s pharmacovigilance department (PVD) is comprised of physicians and life science professionals of varying expertise, providing full pharmacovigilance (PV) services for a wide range of human and veterinary medicinal products. We can support you with safety monitoring throughout the life cycle of your product and implement (local) requirements as and when needed in the EEA (see flow chart below)
DADA has available a network of qualified local QPPV partners in a significant number of EEA countries, which we will use when you need advice and support in establishment of your local QPPV network.
In late 2019, the DADA PVD branched into two specialised teams for Safety Data Management (SDM) and Benefit Risk Management (BRM). Working closely together, from the DADA headquarters in the Netherlands and from the local office in Poland, we provide the following vigilance services for our clients: